RESPONSE BIOMEDICAL CORP

2.01,3.03,5.01,5.02,8.01,9.01

Certification of termination of registration of a class of securities (Section 12(g))

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

No description available

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

5.07,8.01,9.01

2.02,9.01

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

No description available

No description available

Correspondence with the SEC

No description available

No description available

Letter from the SEC

Correspondence with the SEC

No description available

No description available

Letter from the SEC

No description available

No description available

Entry into a Material Definitive Agreement

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Additional Information for Proxy Statement/ Votes

Submission of Matters to a Vote of Security Holders

Specialized Disclosure Report

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

2.02,9.01

5.02

8.01,9.01

3.01,8.01,9.01

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

5.02

No description available

9.01

Specialized Disclosure Report

5.02,5.07,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

No description available

Definitive Proxy Statement

2.02,9.01

Annual report pursuant to Section 13 or 15(d)

9.01

No description available

1.01,8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Specialized Disclosure Report

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

No description available

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

06c

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual Report Scanned (Paper)

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

06

Rule 506

06

06

06

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

No description available

No description available

Kinnaird-Steen Barbara

HOLLER ANTHONY F

KEEGAN JOSEPH D

Shuster Lewis

SEVERSON CLINTON

Adams William J.

ISALY SAMUEL D

Thompson Peter A.

Wang Jonathan Jian

Thompson Peter A.

Wang Jonathan Jian

OrbiMed Advisors Ltd; ISALY SAMUEL D; ORBIMED ASIA GP, LP; OrbiMed Capital GP III LLC; ORBIMED ADVISORS LLC

Adams William J.